Efficacy and safety of rivaroxaban versus apixaban for venous thromboembolism: A systematic review and meta-analysis of observational studies
2023 · Journal of Thrombosis and Thrombolysis · 11 citations
https://doi.org/10.1007/s11239-023-02926-3
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
7
Papers
21
Citations
3
h-index
1
i10-index
Ofir Eldar is an academic researcher from Rabin Medical Center. The author has contributed to research in topics: Venous Thromboembolism Diagnosis and Management & Central Venous Catheters and Hemodialysis & COVID-19 Clinical Research Studies. The author has an h-index of 3, co-authored 6 publications.
Click to start Chat